• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于对接的虚拟筛选及从褐藻中鉴定潜在的新冠病毒主要蛋白酶抑制剂

Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.

作者信息

Rauf Abdur, Rashid Umer, Khalil Anees Ahmed, Khan Shahid Ali, Anwar Sirajudheen, Alafnan Ahmed, Alamri Abdulhakeem, Rengasamy Kannan Rr

机构信息

Department of Chemistry, University of Swabi, Anbar, K.P.K 23561, Pakistan.

Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, 22060, Pakistan.

出版信息

S Afr J Bot. 2021 Dec;143:428-434. doi: 10.1016/j.sajb.2021.06.033. Epub 2021 Jul 1.

DOI:10.1016/j.sajb.2021.06.033
PMID:34226782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8245353/
Abstract

COVID-19 (SARS-CoV-2) is a viral disease that causes acute respiratory syndrome, which has increased the morbidity and mortality rate throughout the world. World Health Organization has declared this COVID-19 outbreak as pandemic and classified health emergency throughout the world. In the recent past, outbreaks of SARS and MERS have shown the interspecies transmission potential of coronaviruses and limitations of already prescribed drugs to overcome this global public health issue. Therefore, there is a dire need to identify a new regimen of targeted drugs from natural compounds having anti-COVID19 potential. This study aimed at screening 1018 brown algal natural compounds (many of them previously reported to have immunomodulatory effects) having probable anti-COVID19 potentials. The source compounds were extracted from MarinLit, a database dedicated to marine natural products and screened against COVID-19 main protease. The top seven compounds were further analysed, and their interactions with the active site were visualized. This study will further warrant screening the potent compounds against the virus conditions.

摘要

新冠病毒(严重急性呼吸综合征冠状病毒2)是一种引发急性呼吸综合征的病毒性疾病,已导致全球发病率和死亡率上升。世界卫生组织已宣布此次新冠疫情为全球大流行,并将其列为全球卫生紧急事件。近期,非典和中东呼吸综合征疫情已显示出冠状病毒的跨物种传播潜力,以及现有处方药在应对这一全球公共卫生问题方面的局限性。因此,迫切需要从具有抗新冠病毒潜力的天然化合物中确定一种新的靶向药物方案。本研究旨在筛选1018种具有潜在抗新冠病毒能力的褐藻天然化合物(其中许多此前已报道具有免疫调节作用)。这些源化合物从MarinLit(一个专门收录海洋天然产物的数据库)中提取,并针对新冠病毒主要蛋白酶进行筛选。对排名前七的化合物进行了进一步分析,并可视化了它们与活性位点的相互作用。本研究将进一步推动针对病毒条件筛选有效化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/0ae0f0b41b64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/8742ad96e159/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/ad28a7f3468d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/0ae0f0b41b64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/8742ad96e159/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/ad28a7f3468d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7772/8245353/0ae0f0b41b64/gr3_lrg.jpg

相似文献

1
Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.基于对接的虚拟筛选及从褐藻中鉴定潜在的新冠病毒主要蛋白酶抑制剂
S Afr J Bot. 2021 Dec;143:428-434. doi: 10.1016/j.sajb.2021.06.033. Epub 2021 Jul 1.
2
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
3
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
4
Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.针对 SARS-CoV-2 蛋白酶及其两种亚洲突变体的有效植物化学抑制剂的筛选。
Comput Biol Med. 2021 Jun;133:104362. doi: 10.1016/j.compbiomed.2021.104362. Epub 2021 Apr 16.
5
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
6
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors.场模板、QSAR、分子对接集成和 3D-RISM 溶剂化研究揭示了 FDA 批准的海洋药物作为 SARS-CoV-2 主要蛋白酶抑制剂的潜力。
Molecules. 2021 Feb 10;26(4):936. doi: 10.3390/molecules26040936.
7
Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.从已批准的抗病毒药物中通过对接和虚拟筛选发现有效的 SARS-CoV-2 抑制剂。
Comb Chem High Throughput Screen. 2021;24(3):441-454. doi: 10.2174/1386207323999200730205447.
8
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.针对 COVID-19 主蛋白酶的虚拟筛选和再利用 FDA 批准的药物。
Life Sci. 2020 Jun 15;251:117627. doi: 10.1016/j.lfs.2020.117627. Epub 2020 Apr 3.
9
Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.花色苷衍生物作为 SARS-CoV-2 主要蛋白酶的有效抑制剂:针对 COVID-19 大流行的治疗靶点的计算视角。
J Biomol Struct Dyn. 2021 Oct;39(16):6171-6183. doi: 10.1080/07391102.2020.1801510. Epub 2020 Aug 3.
10
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.从印度香料中鉴定新型抗 nCoV 药物化合物,利用 SARS-CoV-2 主要蛋白酶作为靶点。
J Biomol Struct Dyn. 2021 Jun;39(9):3428-3434. doi: 10.1080/07391102.2020.1763202. Epub 2020 May 13.

引用本文的文献

1
Antimicrobial potentials of Pandanus amaryllifolius Roxb.: Phytochemical profiling, antioxidant, and molecular docking studies.药用蒲葵叶的抗菌潜力:植物化学分析、抗氧化和分子对接研究。
PLoS One. 2024 Aug 14;19(8):e0305348. doi: 10.1371/journal.pone.0305348. eCollection 2024.
2
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.通过天然产物对抗 COVID-19:药物化学家的各种尝试的全面更新。
Molecules. 2023 Jun 20;28(12):4860. doi: 10.3390/molecules28124860.
3
Antioxidant effects of seaweeds and their active compounds on animal health and production - a review.

本文引用的文献

1
Natural and Nature-Derived Products Targeting Human Coronaviruses.天然产物和天然衍生产物靶向人类冠状病毒。
Molecules. 2021 Jan 16;26(2):448. doi: 10.3390/molecules26020448.
2
Biologically active compounds from marine organisms in the strategies for combating coronaviruses.对抗冠状病毒策略中来自海洋生物的生物活性化合物。
AIMS Microbiol. 2020 Dec 7;6(4):470-494. doi: 10.3934/microbiol.2020028. eCollection 2020.
3
Potential SARS-CoV-2 main protease inhibitors.潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
海藻及其活性化合物对动物健康和生产的抗氧化作用——综述。
Vet Q. 2022 Dec;42(1):48-67. doi: 10.1080/01652176.2022.2061744.
Drug Discov Today. 2021 Mar;26(3):804-816. doi: 10.1016/j.drudis.2020.12.005. Epub 2020 Dec 9.
4
Macroalgae-A Sustainable Source of Chemical Compounds with Biological Activities.大型藻类——具有生物活性的化合物的可持续来源。
Nutrients. 2020 Oct 11;12(10):3085. doi: 10.3390/nu12103085.
5
Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances.海洋藻类及其生物活性代谢产物的神经保护潜力:药理学研究进展与治疗应用
Mar Drugs. 2020 Jul 1;18(7):347. doi: 10.3390/md18070347.
6
Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.大蒜精油中化合物对新型冠状病毒(SARS-CoV-2)的抗性研究
ACS Omega. 2020 Mar 31;5(14):8312-8320. doi: 10.1021/acsomega.0c00772. eCollection 2020 Apr 14.
7
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.海洋天然产物文库中 SARS-CoV-2 主蛋白酶的假定抑制剂:虚拟筛选和分子建模研究。
Mar Drugs. 2020 Apr 23;18(4):225. doi: 10.3390/md18040225.
8
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.天然产物及其衍生物抗冠状病毒:非临床和临床前数据的综述。
Phytother Res. 2020 Oct;34(10):2471-2492. doi: 10.1002/ptr.6700. Epub 2020 Apr 17.
9
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国,2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
10
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.中药治疗 2019 年新型冠状病毒(SARS-CoV-2)感染患者:综述与展望。
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.